Resistant Infection
7
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics
Mycosis Culture Collection From Dermatological Isolated
HIV Drug Resistance Pattern Due to Migration in Poland
One Sequencing Find All for Helicobacter Pylori Infection
Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
Optimization Management Study of Community Urinary Tract Infections Spectrum